+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Blood Cancer Drug"

Blood Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Blood Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
T-Cell Blood Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

T-Cell Blood Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026 - Product Thumbnail Image

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026

  • Report
  • November 2021
  • 222 Pages
  • Global
From
Blood Cancer Therapeutics: Global Markets to 2023 - Product Thumbnail Image

Blood Cancer Therapeutics: Global Markets to 2023

  • Report
  • December 2018
  • 174 Pages
  • Global
From
Oncology Drugs Global Market Opportunities and Strategies to 2032 - Product Thumbnail Image

Oncology Drugs Global Market Opportunities and Strategies to 2032

  • Report
  • April 2023
  • 501 Pages
  • Global
From
Hematological Cancer (Blood Cancer) Therapeutics - Market Insights, Competitive Landscape and, Market Forecast - 2027 - Product Thumbnail Image

Hematological Cancer (Blood Cancer) Therapeutics - Market Insights, Competitive Landscape and, Market Forecast - 2027

  • Report
  • September 2022
  • 100 Pages
  • Global
From
T-Cell Blood Cancer - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

T-Cell Blood Cancer - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Global Hematological Cancer (Blood Cancer) Therapy Market to 2027 - Comprehensive Overview of Marketed and Pipeline Products, Opportunities, Challenges, Market Size and Key Players - Product Thumbnail Image

Global Hematological Cancer (Blood Cancer) Therapy Market to 2027 - Comprehensive Overview of Marketed and Pipeline Products, Opportunities, Challenges, Market Size and Key Players

  • Report
  • August 2021
  • 125 Pages
  • Global
From
Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021 - Product Thumbnail Image

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Catenin Beta 1 - Pipeline Review, H2 2020 - Product Thumbnail Image

Catenin Beta 1 - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 69 Pages
  • Global
From
Blood Cancer Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026 - Product Thumbnail Image

Blood Cancer Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026

  • Report
  • December 2020
  • 100 Pages
  • Global
From
Non Hematological Cancer Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Non Hematological Cancer Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 96 Pages
  • Global
From
Hematological Cancers Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hematological Cancers Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2021
  • 124 Pages
  • Global
From
Catenin Beta 1 (Beta Catenin or CTNNB1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Catenin Beta 1 (Beta Catenin or CTNNB1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 83 Pages
  • Global
From
Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Drugs in Development, 2021 - Product Thumbnail Image

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Serine Threonine Protein Kinase Pim 1 - Pipeline Review, H2 2019 - Product Thumbnail Image

Serine Threonine Protein Kinase Pim 1 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 50 Pages
  • Global
From
Serine Threonine Protein Kinase Pim 3 - Pipeline Review, H2 2019 - Product Thumbnail Image

Serine Threonine Protein Kinase Pim 3 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 41 Pages
  • Global
From
  • 17 Results (Page 1 of 1)
Loading Indicator

The Blood Cancer Drug market is a subset of the Oncology Drugs market, which focuses on the treatment of cancer. Blood cancer drugs are used to treat a variety of blood cancers, including leukemia, lymphoma, and myeloma. These drugs are typically administered intravenously or orally, and may include chemotherapy, targeted therapy, and immunotherapy. Blood cancer drugs are designed to target cancer cells while minimizing damage to healthy cells, and may be used in combination with other treatments. The Blood Cancer Drug market is highly competitive, with a number of large pharmaceutical companies offering a range of treatments. Companies in the market include Novartis, Pfizer, Bristol-Myers Squibb, Celgene, and Merck. Show Less Read more